The genomic landscape and pharmacogenomic interactions of clock genes in cancer chronotherapy

Cancer chronotherapy, treatment at specific times during circadian rhythms, endeavors to optimize anti-tumor effects and lower toxicity. However, comprehensive characterization of clock genes and their clinical relevance in cancer is lacking. We systematically characterized the alterations of clock...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Syst
Autors principals: Ye, Youqiong, Xiang, Yu, Ozguc, Fatma Muge, Kim, Yoonjin, Liu, Chun-Jie, Park, Peter K., Hu, Qingsong, Diao, Lixia, Lou, Yanyan, Lin, Chunru, Guo, An-Yuan, Zhou, Bingying, Wang, Li, Chen, Zheng, Takahashi, Joseph S., Mills, Gordon B., Yoo, Seung-Hee, Han, Leng
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6056007/
https://ncbi.nlm.nih.gov/pubmed/29525205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cels.2018.01.013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars